Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer

Ask the Expert: Understanding the Latest Advances in Breast CancerПодробнее

Ask the Expert: Understanding the Latest Advances in Breast Cancer

Medical advances in the treatment of metastatic breast cancerПодробнее

Medical advances in the treatment of metastatic breast cancer

Latest Advances in Systemic Treatment for Breast Cancer: Evidence and ImplicationsПодробнее

Latest Advances in Systemic Treatment for Breast Cancer: Evidence and Implications

Ask the Expert: New treatments in metastatic breast cancerПодробнее

Ask the Expert: New treatments in metastatic breast cancer

Ask the Expert: Advances in Metastatic Breast CancerПодробнее

Ask the Expert: Advances in Metastatic Breast Cancer

Ask the expert: Metastatic breast cancer with Tufia C. Haddad, MDПодробнее

Ask the expert: Metastatic breast cancer with Tufia C. Haddad, MD

Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Emerging Data and Future ImplicationsПодробнее

Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Emerging Data and Future Implications

Breast Cancer Breakthroughs Episode 11: Changing the Game with New Hormone TherapiesПодробнее

Breast Cancer Breakthroughs Episode 11: Changing the Game with New Hormone Therapies

Metastatic Breast Cancer | 2022 OneOncology ConferenceПодробнее

Metastatic Breast Cancer | 2022 OneOncology Conference

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancerПодробнее

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer

Dr. Krop on the Impact of Recent Advances in Breast CancerПодробнее

Dr. Krop on the Impact of Recent Advances in Breast Cancer

Expert Perspectives: CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast CancerПодробнее

Expert Perspectives: CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast Cancer

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancerПодробнее

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer

#ESMO21 Expert Video Report on HER2-positive metastatic breast cancerПодробнее

#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer

Clinical Trials for Metastatic Breast Cancer: What You Should Know | Dana-Farber Cancer InstituteПодробнее

Clinical Trials for Metastatic Breast Cancer: What You Should Know | Dana-Farber Cancer Institute

Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical UseПодробнее

Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical Use

2021 West Oncology | Breast Cancer | New Advances for Metastatic TNBCПодробнее

2021 West Oncology | Breast Cancer | New Advances for Metastatic TNBC

Advances in Breast Cancer Treatment WebinarПодробнее

Advances in Breast Cancer Treatment Webinar

Research Advances in Inflammatory and Lobular Metastatic Breast CancerПодробнее

Research Advances in Inflammatory and Lobular Metastatic Breast Cancer

Новости